Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 1.41 Billion |
| USD 3.74 Billion | |
| % | |
|
Europe Ventilators Market, By Product Type (Intensive Care Ventilators, Portable Ventilators and Neonatal Ventilators), Modality (Non-Invasive Ventilation and Invasive Ventilation), Type (Adult, Paediatric and Neonatal), Mode (Combined- Mode Ventilation, Volume- Mode Ventilation, Pressure- Mode Ventilation and Other), End User (Hospitals and Clinics, Home Care, Ambulatory Centres, Speciality Clinics, Rehabilitation Centres, Long Term Care Centres, Homecare Settings and Others)- Industry Trends and Forecast to 2033
The Europe Ventilators market was valued at USD 1.41 billion in 2025 and is projected to reach USD 3.74 billion by 2033, growing at a CAGR of 13.00% from 2026 to 2033. The market is witnessing steady growth driven by the rising prevalence of respiratory diseases, increasing demand for critical care infrastructure, and continuous advancements in portable and non-invasive ventilation technologies.
The growing burden of chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections across Europe, along with the rapidly aging population, is accelerating the adoption of advanced ventilatory support systems in hospitals, homecare settings, and emergency medical services. In addition, government investments in healthcare preparedness following the COVID-19 pandemic and the increasing integration of AI-enabled monitoring, smart sensors, and remote patient management technologies are further supporting market expansion. Portable ventilators and intensive care ventilators are gaining significant traction due to their improved mobility, operational efficiency, and ability to deliver precise respiratory support in both acute and long-term care environments.
Key Market Trends & Insights
Market Size & Forecast
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Europe Ventilators Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
Europe
· Germany
· France
· U.K.
· Netherlands
· Switzerland
· Belgium
· Russia
· Italy
· Spain
· Turkey
· Rest of Europe
|
|
Key Market Players
|
· Medtronic (Ireland)
· Koninklijke Philips N.V. (Netherlands)
· Drägerwerk AG & Co. KGaA (Germany)
· Getinge AB (Sweden)
· Fisher & Paykel Healthcare Limited (New Zealand)
· ResMed Inc. (U.S.)
· VYAIRE MEDICAL, INC. (U.S.)
· GE HealthCare (U.S.)
· Smiths Group (U.K.)
· Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
· NIHON KOHDEN CORPORATION (Japan)
· Air Liquide (France)
· Hamilton Medical AG (Switzerland)
· BPL Medical Technologies Private Limited (India)
· Premier Medical Systems and Devices Pvt. Ltd. (India)
· Avasarala Technologies Limited (India)
· Metran Co., Ltd. (Japan)
· HEYER Medical AG (Germany)
· Allied Healthcare Products, Inc. (U.S.)
· ZOLL Medical Corporation (U.S.)
|
|
Market Opportunities
|
· Rising expansion of home healthcare services
· Increasing investments in rural and secondary hospital ICU infrastructure
· Growing adoption of AI-enabled smart ventilators for predictive monitoring and automated respiratory management
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Trend: Rising Adoption of Portable and Homecare Ventilation Systems
Healthcare providers across Europe are increasingly adopting portable and homecare ventilators to improve long-term respiratory care, reduce hospital stays, and support aging populations suffering from chronic pulmonary disorders. The integration of compact designs, wireless monitoring capabilities, and AI-enabled respiratory analytics enables continuous patient supervision and efficient treatment management outside traditional hospital environments. Home healthcare agencies and rehabilitation centers are similarly utilizing portable ventilators to deliver personalized respiratory support through standardized, technology-driven care models, while smart connectivity solutions create seamless monitoring ecosystems that closely replicate intensive care supervision conditions.
Key Market Driver: Increasing Prevalence of Chronic Respiratory Diseases Across Europe
The growing prevalence of chronic respiratory diseases and critical care admissions has created substantial demand for advanced ventilators capable of delivering precise respiratory support across intensive care, emergency, and long-term treatment settings. Hospitals, healthcare systems, and medical device manufacturers are deploying technologically advanced ventilators as a core component of respiratory care infrastructure, reducing mortality risks, improving patient outcomes, and supporting efficient clinical workflow management.
For instance, in March 2024, Dräger introduced enhanced ICU ventilation solutions across European healthcare facilities to strengthen critical respiratory care capabilities and improve patient monitoring efficiency.
Key Restraint/Challenge: High Procurement and Maintenance Costs of Advanced Ventilator Systems
A significant restraint in the Europe ventilators market is the high upfront investment required for technologically advanced ventilation systems. Modern ventilators integrate intelligent monitoring software, precision airflow control systems, touchscreen interfaces, and remote connectivity functions, demanding substantial expenditure for procurement, installation, maintenance, and periodic software upgrades. The total ownership cost further extends to staff training, technical servicing, and regulatory compliance requirements, making adoption challenging for smaller healthcare facilities, rehabilitation centers, and budget-constrained medical institutions across developing European regions.
For instance, in September 2024, Getinge expanded its advanced ventilator portfolio for European hospitals, highlighting the significant infrastructure and operational investments associated with next-generation respiratory care technologies.
Key Market Opportunity: Expansion of AI-Integrated Smart Ventilation Technologies
The integration of artificial intelligence and smart monitoring technologies in ventilators presents a significant market opportunity. AI-enabled ventilation platforms can optimize airflow delivery, provide predictive respiratory analytics, and support real-time patient monitoring for improved critical care management. The development of cloud-connected respiratory systems and remote patient supervision platforms is further expanding access to advanced ventilation technologies, creating growth opportunities across hospitals, homecare settings, and emergency medical services throughout Europe. For instance, in May 2024, Philips expanded connected respiratory care solutions across Europe, supporting AI-driven patient monitoring and integrated ventilation management capabilities.
The Europe ventilators market is segmented on the basis of product type, modality, type, mode, and end user.
On the basis of product type, the Europe ventilators market is segmented into intensive care ventilators, portable ventilators, and neonatal ventilators. The Intensive Care Ventilators segment dominated the market with a 46.18% share in 2025, owing to the growing number of ICU admissions, rising prevalence of chronic respiratory diseases, and increasing demand for advanced respiratory support systems across hospitals. These ventilators are extensively used for managing critically ill patients requiring continuous respiratory monitoring and precise airflow management. Hospitals and critical care centers rely heavily on intensive care ventilators for emergency treatment, surgical recovery, and severe pulmonary conditions. Technological advancements such as AI-assisted monitoring, touchscreen interfaces, and integrated alarm systems are further strengthening segment growth. Increasing healthcare expenditure and government investments in critical care infrastructure are also supporting widespread adoption. Their ability to deliver accurate and long-term respiratory assistance continues to maintain their dominance across Europe.
The Portable Ventilators segment is projected to register the fastest growth at a CAGR of 6.7% from 2026 to 2033, driven by rising demand for home healthcare, emergency medical transport, and ambulatory respiratory support solutions. These ventilators provide mobility, compact design, and operational flexibility for patients requiring continuous respiratory assistance outside hospital environments. Increasing preference for home-based treatment and remote patient monitoring is accelerating product adoption across Europe. Advancements in battery technology, lightweight systems, and wireless connectivity are significantly improving device efficiency and patient convenience. Growing geriatric populations and rising prevalence of chronic respiratory disorders are further supporting market expansion. Emergency response services and military healthcare applications are also contributing to increased deployment. The shift toward decentralized healthcare delivery models continues to create strong growth opportunities for portable ventilators.
On the basis of modality, the Europe ventilators market is segmented into non-invasive ventilation and invasive ventilation. The Invasive Ventilation segment dominated the market with a 58.42% share in 2025 due to its extensive use in intensive care units and emergency treatment settings for critically ill patients. These systems are widely utilized for patients experiencing severe respiratory failure, trauma, and surgical complications requiring direct airway intervention. Hospitals prefer invasive ventilation systems because they provide precise respiratory control and continuous oxygen delivery during critical care procedures. Technological improvements in ventilation monitoring and airflow management are further increasing treatment efficiency. Rising incidence of respiratory infections and chronic pulmonary diseases across Europe is supporting higher adoption rates. Strong availability of advanced ICU infrastructure and skilled healthcare professionals also contributes to segment dominance. Their essential role in life-support treatment continues to sustain long-term market demand.
The Non-Invasive Ventilation segment is expected to witness the fastest growth at a CAGR of 6.5% from 2026 to 2033, driven by increasing preference for less invasive respiratory support methods and reduced hospitalization risks. These ventilation systems improve patient comfort while minimizing complications associated with intubation and prolonged ICU stays. Growing use in homecare settings for sleep apnea, COPD, and chronic respiratory disease management is significantly accelerating adoption. Continuous advancements in mask technologies, portable devices, and smart monitoring systems are improving treatment outcomes and operational convenience. Healthcare providers are increasingly promoting non-invasive ventilation to reduce healthcare costs and improve patient recovery rates. Rising awareness regarding early respiratory intervention and preventive care is also contributing to segment expansion. Expanding demand for outpatient respiratory care services continues to support rapid market growth.
On the basis of type, the Europe ventilators market is segmented into adult, paediatric, and neonatal. The Adult segment dominated the market with a 45.83% revenue share in 2025, driven by the increasing prevalence of respiratory disorders among the aging population across Europe. Adult ventilators are extensively utilized in hospitals, long-term care centers, and emergency medical facilities for the treatment of COPD, pneumonia, and acute respiratory distress syndrome. Rising ICU admissions and surgical procedures are significantly increasing the demand for advanced adult respiratory support systems. Healthcare providers are investing heavily in technologically advanced ventilators with intelligent monitoring and automated ventilation adjustment features. Increasing smoking-related illnesses and chronic pulmonary conditions are further strengthening segment dominance. The strong availability of reimbursement support and advanced healthcare infrastructure also supports continued market expansion. Their broad application range across acute and chronic respiratory care maintains their leading position.
The Neonatal segment is projected to register the fastest growth at a CAGR of 6.8% from 2026 to 2033, driven by the increasing incidence of premature births and rising demand for specialized neonatal intensive care services. Neonatal ventilators are specifically designed to provide highly precise and low-pressure respiratory support for newborns with underdeveloped lungs and respiratory complications. Advancements in neonatal care technologies and increasing investments in pediatric healthcare infrastructure are accelerating adoption across European hospitals. Growing awareness regarding infant respiratory health and improved survival rates of premature infants are also supporting market growth. Healthcare institutions are increasingly adopting compact and high-precision neonatal ventilation systems to improve treatment outcomes and reduce complications. Government healthcare initiatives focused on maternal and child health are further contributing to segment expansion. Rising demand for specialized neonatal critical care continues to create significant growth opportunities.
On the basis of mode, the Europe ventilators market is segmented into combined-mode ventilation, volume-mode ventilation, pressure-mode ventilation, and other. The Volume-Mode Ventilation segment dominated the market with a 39.64% share in 2025 owing to its widespread use in intensive care settings requiring controlled and consistent airflow delivery. These systems provide accurate tidal volume management, making them highly suitable for critically ill patients requiring stable respiratory assistance. Hospitals and emergency care units extensively utilize volume-mode ventilation for surgical recovery, respiratory distress management, and long-term ventilation support. Increasing adoption of advanced monitoring systems and automated respiratory controls is further improving treatment precision and patient safety. Rising incidence of chronic pulmonary disorders and critical respiratory conditions across Europe is supporting segment demand. The availability of technologically advanced ICU infrastructure also strengthens adoption across healthcare facilities. Their reliability and effectiveness in controlled ventilation therapy continue to support market leadership.
The Combined-Mode Ventilation segment is expected to witness the fastest growth at a CAGR of 6.6% from 2026 to 2033, driven by increasing demand for flexible and adaptive respiratory support technologies. These systems combine pressure and volume ventilation benefits, enabling personalized treatment based on patient respiratory conditions and changing clinical requirements. Healthcare providers are increasingly adopting combined-mode systems to improve patient comfort, optimize ventilation efficiency, and reduce treatment complications. Technological advancements in AI-assisted ventilation controls and real-time respiratory monitoring are significantly enhancing system performance. Growing emphasis on precision medicine and individualized respiratory therapy is further accelerating adoption across Europe. Hospitals are also utilizing combined-mode ventilation to improve workflow efficiency and patient management in critical care settings. Rising investments in smart respiratory technologies continue to create strong market growth potential.
On the basis of end user, the Europe ventilators market is segmented into hospitals and clinics, home care, ambulatory centres, speciality clinics, rehabilitation centres, long term care centres, homecare settings, and others. The Hospitals and Clinics segment dominated the market with a 61.24% share in 2025 due to the high concentration of critical care admissions, respiratory emergencies, and surgical procedures across Europe. Hospitals remain the primary healthcare facilities for advanced respiratory treatment and intensive care ventilation management. Increasing investments in ICU expansion, emergency preparedness, and advanced healthcare infrastructure are significantly driving ventilator adoption in hospitals and clinics. The availability of skilled healthcare professionals and advanced patient monitoring systems further strengthens segment dominance. Rising prevalence of respiratory infections, chronic lung diseases, and cardiovascular complications is also increasing demand for hospital-based respiratory support systems. Government healthcare funding and modernization initiatives continue to support market expansion. Their central role in acute and emergency respiratory care sustains long-term leadership.
The Home Care segment is projected to register the fastest growth at a CAGR of 6.9% from 2026 to 2033, driven by increasing preference for home-based respiratory treatment and long-term chronic disease management. Homecare ventilators provide improved patient convenience, reduced hospitalization costs, and continuous respiratory support in non-clinical environments. Growing geriatric populations and rising prevalence of chronic respiratory disorders are significantly increasing demand for home ventilation systems across Europe. Advancements in portable ventilators, remote monitoring technologies, and wireless connectivity are enhancing patient safety and operational efficiency. Healthcare providers and insurance systems are increasingly supporting home-based treatment models to reduce healthcare facility burden and improve patient quality of life. Rising awareness regarding personalized respiratory care and rehabilitation services is also accelerating market adoption. Continuous expansion of telehealth and remote patient monitoring infrastructure further supports segment growth.
Germany dominated the Europe ventilators market with the largest revenue share of 28.46% in 2025, supported by advanced healthcare infrastructure, high ICU bed capacity, and strong government investments in critical care technologies. The country also benefits from the rising prevalence of chronic respiratory diseases, growing adoption of portable and AI-enabled ventilators, and expanding utilization of advanced respiratory support systems across hospitals, homecare settings, and emergency medical services. Increasing focus on patient monitoring, remote respiratory management, and technologically advanced intensive care solutions continues to strengthen Germany’s leadership position within the Europe ventilators market.
The Germany Ventilators Market Insight
The Germany ventilators market is expanding steadily due to the country’s advanced healthcare infrastructure, strong medical technology industry, and increasing adoption of next-generation respiratory care solutions. Hospitals, healthcare providers, and rehabilitation centers are increasingly utilizing ventilators for critical care management, chronic respiratory disease treatment, and emergency medical support. Continuous advancements in AI-integrated monitoring, smart ventilation systems, and portable respiratory devices, along with strong government focus on healthcare modernization and patient safety, are further driving market growth in Germany.
U.K. Ventilators Market Insight
The U.K. ventilators market is experiencing steady growth, supported by rising adoption of advanced respiratory support technologies in hospitals, emergency care, and home healthcare applications. Increasing investments in modern healthcare infrastructure and growing demand for efficient, patient-centric ventilation systems are contributing to market growth. Furthermore, integration of AI-enabled monitoring, remote respiratory management, and portable ventilation technologies is improving treatment efficiency and patient outcomes, positioning the U.K. as a key innovation hub in the ventilators industry.
France Ventilators Market Insight
The France ventilators market is witnessing significant growth due to rising demand for advanced respiratory care systems, increasing prevalence of chronic pulmonary diseases, and expanding healthcare modernization initiatives. Hospitals and critical care facilities are increasingly adopting technologically advanced ventilators to improve patient management and treatment efficiency. Growing investments in ICU infrastructure, portable respiratory devices, and connected healthcare technologies are further supporting market expansion. In addition, strong government healthcare support and increasing focus on emergency preparedness continue to strengthen ventilator adoption across France.
Poland Ventilators Market Insight
The Poland ventilators market is witnessing rapid growth due to expanding healthcare infrastructure, increasing investments in critical care facilities, and rising demand for advanced respiratory support systems. Hospitals and healthcare providers are increasingly adopting modern ventilators to improve intensive care treatment, emergency response capabilities, and long-term respiratory disease management. Growing prevalence of chronic pulmonary disorders and increasing awareness regarding respiratory healthcare are significantly supporting market demand. Furthermore, government healthcare modernization initiatives and rising adoption of portable and non-invasive ventilation technologies are accelerating ventilator market growth across Poland.
The Europe Ventilators industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.